Fig. 2From: Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's diseaseThe cumulative continuation rate of anti-TNFα agents was calculated by using the Kaplan–Meier curve. A There is no significant difference between IFX users and ADA users. B A significant difference can be observed between patients with a baseline CRP level ≥ 1 mg/dL and those with a baseline CRP level < 1 mg/dLBack to article page